Arthroereisis Versus Lateral Column Lengthening in the Treatment of Planovalgus Feet
NCT ID: NCT02055495
Last Updated: 2014-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2010-03-31
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Subtalar Arthroereisis With Endorthesis for Pediatric Flexible Flat Foot
NCT03372642
Return To Sport Activities in Patients Surgically Treated For Flat Foot in Paeditric Age
NCT04269421
Outcomes of the Evans Calcaneal Lengthening Based on Bone Grafting Material
NCT02075853
Arthrorisis of the Subtalar Joint With a Polymeric Endorthesis for Flexible Flatfoot Treatment During the Growth Age Prospective Evaluation
NCT06091371
Evaluation of Clinical and Functional Results After Operative Correction of Lesser Toe Deformities
NCT04949685
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A prospective trial was conducted. The investigators enrolled fifteen patients (mean age 12.8y, 24 feet) with painful, planovalgus feet refractory to conservative treatment. Seven patients (13 feet) were enrolled in the arthroereisis group, and eight patients (11 feet) were enrolled in the calcaneal lengthening group. Though not specifically excluded, none of the enrolled patients had an underlying neuromuscular diagnosis. Kinematic motion analysis was performed on each patient prior to surgery and at one year of follow-up. Pedobarometry studies, radiographs, and validated outcome questionnaires (Oxford Ankle-Foot Questionnaire for Children) were also performed to evaluate the outcomes of both groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient normally ambulates without use of assistive devices
* Patient is between the ages of 7 and 17 at the initial evaluation
Exclusion Criteria
* Knee flexion contractures greater than 10 deg.
* Ankle dorsiflexion less than 0 deg. (plantarflexion contracture)
* Taking medication which effects motor control
* Inability to follow instructions to perform study
7 Years
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Utah
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bruce MacWilliams
Associate Professor, Director, Movement Analysis Laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruce MacWilliams, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Utah
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shriners Hospitals for Children
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40286
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.